FASN and non-Hodgkin lymphoma: Similar metabolic variations with suppression of nucleotide metabolism accompanied by increased glycolytic activity were observed in our recent studies investigating the impact of fatty acid synthase (FASN) inhibition on the nucleotide metabolism in non-Hodgkin’s lymphoma [107].